Form 4: Elanco Animal Health CEO Acquires Deferred Stock Units
SEC Form 4 Filing
Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.
Summary
- On January 24, 2025, Jeffrey N. Simmons, the President, CEO, and Director of Elanco Animal Health Inc., acquired 229.2417 deferred stock units.
- These units represent the right to receive one share of Elanco's common stock or the cash equivalent.
- The price of the derivative security was $12.08.
- Following the transaction, Simmons directly owns 5,464.0537 derivative securities.
- The deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard SEC filing related to executive compensation. The acquisition of stock units by the CEO can be seen as a positive sign, but it's not a major event.
Positives
- The acquisition of deferred stock units by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Industry Context
Executive compensation through stock and deferred stock units is a common practice in the animal health industry to align management's interests with those of shareholders.
Comparison to Industry Standards
- Companies like Zoetis and Merck Animal Health also utilize stock-based compensation for their executives.
- The specific terms of Elanco's Executive Deferral and Stock Match Plan would need to be compared to those of its peers to assess its competitiveness.
Stakeholder Impact
- The acquisition of deferred stock units by the CEO aligns his interests with those of the shareholders.
- This could potentially motivate him to make decisions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 01/24/2025 | Date of transaction: Acquisition of deferred stock units. |
| 01/28/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.